384 related articles for article (PubMed ID: 31410206)
1. C-myc/miR-150/EPG5 axis mediated dysfunction of autophagy promotes development of non-small cell lung cancer.
Li H; Liu J; Cao W; Xiao X; Liang L; Liu-Smith F; Wang W; Liu H; Zhou P; Ouyang R; Yuan Z; Liu J; Ye M; Zhang B
Theranostics; 2019; 9(18):5134-5148. PubMed ID: 31410206
[No Abstract] [Full Text] [Related]
2. LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p/c-Myc axis.
Hua Q; Jin M; Mi B; Xu F; Li T; Zhao L; Liu J; Huang G
J Hematol Oncol; 2019 Sep; 12(1):91. PubMed ID: 31488218
[TBL] [Abstract][Full Text] [Related]
3. The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway.
Liu M; Zhou K; Huang Y; Cao Y
J Exp Clin Cancer Res; 2015 Oct; 34():121. PubMed ID: 26467212
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
Guo D; Wang Y; Ren K; Han X
Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-1 overexpression increases chemosensitivity of non-small cell lung cancer cells by inhibiting autophagy related 3-mediated autophagy.
Hua L; Zhu G; Wei J
Cell Biol Int; 2018 Sep; 42(9):1240-1249. PubMed ID: 29851226
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of long noncoding RNA MINCR promotes non-small cell of lung cancer growth by negatively regulating miR-126/SLC7A5 axis.
Wang J; Ding M; Zhu H; Cao Y; Zhao W
Biochem Biophys Res Commun; 2019 Jan; 508(3):780-784. PubMed ID: 30528230
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of LINC01296 suppresses non-small-cell lung cancer via targeting miR-143-3p/ATG2B.
Li Y; Zhang H; Guo J; Li W; Wang X; Zhang C; Sun Q; Ma Z
Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1681-1690. PubMed ID: 34695177
[TBL] [Abstract][Full Text] [Related]
8. MiR-376a suppresses the proliferation and invasion of non-small-cell lung cancer by targeting c-Myc.
Wang Y; Cong W; Wu G; Ju X; Li Z; Duan X; Wang X; Gao H
Cell Biol Int; 2018 Jan; 42(1):25-33. PubMed ID: 28741879
[TBL] [Abstract][Full Text] [Related]
9. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
10. c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer.
Cui J; Mo J; Luo M; Yu Q; Zhou S; Li T; Zhang Y; Luo W
Int J Clin Exp Pathol; 2015; 8(10):12400-9. PubMed ID: 26722426
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
[TBL] [Abstract][Full Text] [Related]
12. MiR-106b-5p Promotes Proliferation and Inhibits Apoptosis by Regulating BTG3 in Non-Small Cell Lung Cancer.
Wei K; Pan C; Yao G; Liu B; Ma T; Xia Y; Jiang W; Chen L; Chen Y
Cell Physiol Biochem; 2017; 44(4):1545-1558. PubMed ID: 29197876
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-1204 promotes cell proliferation by regulating PITX1 in non-small-cell lung cancer.
Jiang W; He Y; Shi Y; Guo Z; Yang S; Wei K; Pan C; Xia Y; Chen Y
Cell Biol Int; 2019 Mar; 43(3):253-264. PubMed ID: 30549141
[TBL] [Abstract][Full Text] [Related]
14. The Vici Syndrome Protein EPG5 Is a Rab7 Effector that Determines the Fusion Specificity of Autophagosomes with Late Endosomes/Lysosomes.
Wang Z; Miao G; Xue X; Guo X; Yuan C; Wang Z; Zhang G; Chen Y; Feng D; Hu J; Zhang H
Mol Cell; 2016 Sep; 63(5):781-95. PubMed ID: 27588602
[TBL] [Abstract][Full Text] [Related]
15. Gastric Adenocarcinoma Predictive Long Intergenic Non-Coding RNA Promotes Tumor Occurrence and Progression in Non-Small Cell Lung Cancer via Regulation of the miR-661/eEF2K Signaling Pathway.
Gu H; Chen J; Song Y; Shao H
Cell Physiol Biochem; 2018; 51(5):2136-2147. PubMed ID: 30522114
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-142-3p/MALAT1 inhibits lung cancer progression through repressing β-catenin expression.
Liu J; Tian W; Zhang W; Jia Y; Yang X; Wang Y; Zhang J
Biomed Pharmacother; 2019 Jun; 114():108847. PubMed ID: 30970294
[TBL] [Abstract][Full Text] [Related]
17. miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc.
Chen Z; Zeng H; Guo Y; Liu P; Pan H; Deng A; Hu J
J Exp Clin Cancer Res; 2010 Nov; 29(1):151. PubMed ID: 21092188
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer.
Cui R; Meng W; Sun HL; Kim T; Ye Z; Fassan M; Jeon YJ; Li B; Vicentini C; Peng Y; Lee TJ; Luo Z; Liu L; Xu D; Tili E; Jin V; Middleton J; Chakravarti A; Lautenschlaeger T; Croce CM
Proc Natl Acad Sci U S A; 2015 Aug; 112(31):E4288-97. PubMed ID: 26187928
[TBL] [Abstract][Full Text] [Related]
19. MiR-449c targets c-Myc and inhibits NSCLC cell progression.
Miao LJ; Huang SF; Sun ZT; Gao ZY; Zhang RX; Liu Y; Wang J
FEBS Lett; 2013 May; 587(9):1359-65. PubMed ID: 23507140
[TBL] [Abstract][Full Text] [Related]
20. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
